Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation

Exclusion Criteria

• •Target lesion involving a bifurcation with a side branch ≥2.0 mm in diameter;
• •Target lesion located in the left main stem;
• •Target lesion is located or supplied by an arterial or venous bypass graft;
• •Lesion located very distally, difficult to be imaged by OCT;
• •Co-morbidities that could interfere with completion of study procedures, or life expectancy less than 1 year;
• •Participating in another investigational drug or device trial that has not completed the primary endpoint or would interfere with the endpoints of this study;
• •Patient underwent target vessel revascularization with a DES;
• •Patient presenting with acute myocardial infarction with ST elevation;
• •Cerebrovascular accident within the past 12 months;
• •Acute or chronic renal dysfunction (defined as creatinine greater than 2.0 mg/dl);
• •Patient receiving oral anticoagulants